濮阳东方医院治阳痿价格公开(濮阳东方医院男科治疗早泄很正规) (今日更新中)

BEIJING, Jan. 23 (Xinhua) -- Nearly 200,000 local residents and tourists visited parks in Beijing on Monday as a series of celebrations were hosted to mark the first day of the Chinese lunar New Year, the city's park administration said.Festive activities kicked off at Beijing's famous parks, including the Temple of Heaven, the Summer Palace, and the Beihai Park, on Monday to welcome the Year of the Dragon, said Chen Zhiqiang, spokesman for the Beijing Municipal Administration Center of Parks.At the Temple of Heaven, 320 costumed performers on Monday staged a show presenting the royal heaven worship ceremony in the Qing Dynasty (1644-1911).In the one-hour ceremony, thousands of visitors watched as the royal parade marched toward the altar where the "emperor" held a ritual to pray for peace and good harvest in the coming year.At the Summer Palace, the ancient royal garden, a traditional fair opened to public with old-fashioned shops and stands selling items and snacks popular in the old days.The Chinese New Year, which begins on Monday this year, is an important occasion for family dinners, fireworks, and a trip to temple fairs.To cope with the increase in visitors, authorities in Beijing said they have deployed seven police choppers and 910,000 order-maintaining personnel across the city to prevent the breakout of fires and stampedes.

WASHINGTON, Dec. 5 (Xinhua) -- NASA's Kepler mission has confirmed its first planet in the "habitable zone," a region where liquid water could exist on a planet's surface, the U.S. space agency announced on Monday.The newly-confirmed planet, Kepler-22b, is the smallest yet found to orbit in the middle of the habitable zone of a star similar to Sun. The planet is about 2.4 times the radius of Earth. Scientists don't yet know if Kepler-22b has a predominantly rocky, gaseous or liquid composition, but its discovery is a step closer to finding Earth-like planets.Previous research hinted at the existence of near-Earth-size planets in habitable zones, but clear confirmation proved elusive. Two other small planets orbiting stars smaller and cooler than Sun recently were confirmed on the very edges of the habitable zone, with orbits more closely resembling those of Venus and Mars.Kepler-22's star is a bit smaller than our sun, so its habitable zone is slightly closer in. The diagram shows an artist's rendering of the planet comfortably orbiting within the habitable zone, similar to where Earth circles the sun. Kepler-22b has a yearly orbit of 289 days. The planet is the smallest known to orbit in the middle of the habitable zone of a sun-like star. It's about 2.4 times the size of Earth."This is a major milestone on the road to finding Earth's twin, " said Douglas Hudgins, Kepler program scientist at the NASA Headquarters in Washington. "Kepler's results continue to demonstrate the importance of NASA's science missions, which aim to answer some of the biggest questions about our place in the universe."Kepler discovers planets and planet candidates by measuring dips in the brightness of more than 150,000 stars to search for planets that cross in front, or "transit," the stars. Kepler requires at least three transits to verify a signal as a planet."Fortune smiled upon us with the detection of this planet," said William Borucki, Kepler principal investigator at the NASA Ames Research Center who led the team that discovered Kepler-22b. "The first transit was captured just three days after we declared the spacecraft operationally ready. We witnessed the defining third transit over the 2010 holiday season."The Kepler science team uses ground-based telescopes and the Spitzer Space Telescope to review observations on planet candidates the spacecraft finds. The star field that Kepler observes in the constellations Cygnus and Lyra can only be seen from ground-based observatories in spring through early fall. The data from these other observations help determine which candidates can be validated as planets.Kepler-22b is located 600 light years away. While the planet is larger than Earth, its orbit of 290 days around a Sun-like star resembles that of Earth. The planet's host star belongs to the same class as Sun, called G-type, although it is slightly smaller and cooler.Of the 54 habitable-zone planet candidates reported in February 2011, Kepler-22b is the first to be confirmed. This finding will be published in The Astrophysical Journal.

HAIFA, Israel, Oct. 5 (Xinhua) -- "It's a big day, a celebration shared by Israel, science and the entire world," Israeli researcher Daniel Shechtman, who won the 2011 Nobel Prize in chemistry, said here at a press conference at the Technion- Israel Institute of Technology.Shechtman, 70, has spent the past five decades at Technion. He is also an associate at the Ames Laboratory of the U.S. Department of Energy and has lectured at universities abroad."Thousands of scientists are currently researching the subject I developed and I'm sure that all of them view the prize as their accomplishment too," he told Xinhua, adding that, "Science (in general) wouldn't be here and be as prosperous and intricate as it is if not for the work of thousands of others around the world."The Swedish Royal Academy of Sciences on Wednesday announced Shechtman as the winner of this year's Nobel chemistry prize for his cutting-edge research on quasicrystals, a type of atom form that for decades was considered impossible by the global scientific community.The award panel explained that Shechtman's work, launched in early 1980s, has revolutionized the perception of solid matter.His work forced crstyallographers to revamp their basic conception that atoms inside crystals only have repeating and symmetrical patterns.Shechtman is the 10th Israeli scientist to win the Nobel Prize and the fourth to win the prize in chemistry.Ada Yonat, a researcher at the Weizmann Institute near Tel Aviv, received the chemistry prize in 2009.The announcement from Stockholm captured headlines in Israel, drawing praise from the country's leadership, who said Shechtman's achievement is a testament to the Jewish state's stature as a technological powerhouse.Israeli Prime Minister Benjamin Netanyahu said the winning of the Nobel Prize "expresses our people's intellect.""Every Israeli citizen is happy today and every Jew in the world is proud," a statement issued by Netanyahu's office quoted him as telling the scientist in a telephone call.Israeli President Shimon Peres, who is also a Nobel laureate, later called to congratulate Shechtman."You demonstrate that a thinking person who is hardworking and brave can make groundbreaking scientific discoveries," he said.

BEIJING, Oct. 28 (Xinhuanet) -- Taking aspirin everyday may lower the risk of developing colon cancer for people with the cancer-causing genes, researchers found.The finding was published on Friday in the British medical journal "Lancet".The researchers followed 508 patients with Lynch syndrome, an inherited disorder which increases the risk of developing colon and other cancers.These patients were divided into two groups: members in one group took 600 mg aspirins everyday; another group took only the dummy pills.After 4 years, 10 colon cancer cases were reported among 258 patients who took daily aspirins for at least two years, comparing with 23 cases among 250 patients on dummy pills."This is good news for a very specific population," said Asad Umar, a cancer prevention expert at the U.S. National Cancer Institute.However, the finding doesn't apply to the general public, suggested the lead author of the study John Burn, a geneticist at Newcastle University in England.Only those who are at risk of such diseases should consider taking aspirin regularly, such as people having a family history of colon cancer, he added.

BEIJING, Dec. 29 (Xinhua) -- Chinese authorities broke up more than 1,800 dens that made or sold counterfeit drugs in cases that involved 3.35 billion yuan (530 million U.S. dollars) in a two-year crackdown, according to the State Food and Drug Administration (SFDA).During the campaign, 13 government departments mobilized more than one million law enforcement workers to combat the sale of fake drugs via online advertising or consignment, seizing more than 5,000 kinds of illegal products, said SFDA deputy head Bian Zhenjia Thursday at a meeting.According to Bian, the action also targeted malpractice during the manufacturing process as well as selling non-pharmaceutical products as drugs.In the operation, authorities conducted more than 28,000 on-site inspections in medicine production factories and halted the production of 98 varieties of drugs, Bian said.However, Bian noted that problems still exist, including rampant illegal drug advertising and online sales of fake drugs, improper manufacturing practices and outdated laws and regulations concerning drug safety.Bian said the SFDA will continue to cooperate with other government departments and step up supervision and crackdowns on the online sale of fake drugs.

来源：资阳报